Perbedaan Bundamedik Tbk dan Saraswanti Indoland Development Tbk.: Bundamedik Tbk diperdagangkan di Rp188 (kapitalisasi pasar 1,63 T, volume 24 jam 725,9 rb), sedangkan Saraswanti Indoland Development Tbk. diperdagangkan di Rp113 (kapitalisasi pasar 576,2 M, volume 24 jam 164,77 jt). Perbedaan utamanya: Bundamedik Tbk jauh lebih besar — sekitar 2,8× kapitalisasi pasar Saraswanti Indoland Development Tbk., dan Saraswanti Indoland Development Tbk. lebih aktif diperdagangkan (164,77 jt vs 725,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMHS | SWID | |
|---|---|---|
Kapitalisasi Pasar | 1,63 T | 576,2 M |
Volume | 725,9 rb | 164,77 jt |
Lot | 7,26 rb | 1,65 jt |
Perputaran | 135,94 jt | 19,28 M |
Harga Rata-rata | 187,26 | 117,01 |
Nilai Transaksi | 135,94 jt | 19,28 M |
Harga Ekuilibrium Indikatif | 188 | 113 |
Volume Ekuilibrium Indikatif | 1 | 11,44 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Selengkapnya di halaman BMHS →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Selengkapnya di halaman SWID →